An innovative player in recombinant medicinal products
LFB BIOTECHNOLOGIES, a wholly-owned subsidiary of LFB SA, has its head office in Les Ulis (France) and is a strategic subsidiary of the LFB Group, handling the Group’s biotechnology business.
Within the group, four companies are subsidiaries of LFB BIOTECHNOLOGIES : rEVO Biologics Inc and LFB USA, American subsidiaries; in France, CELLforCURE, industrial player in advanced therapies, and LFB BIOMANUFACTURING, running in Alès (France) a cell culture plant.
THE LFB BIOTECHNOLOGIES STRATEGIC COMMITTEE
President: LFB SA, represented by Denis DELVAL
Dr. Elisabeth HUBERT – Chairman of HAD France SAS – Member of the Strategic committee, LFB BIOTECHNOLOGIES SAS
LFB SA, represented by Denis DELVAL – CEO of LFB SA
LFB SA, represented by Patrick BERGEAT – Operations Deputy General Manager, Industrial Executive Vice-President, LFB BIOMÉDICAMENTS
LFB SA, represented by Stéphane VALET – Executive Vice-President, Human Resources, LFB SA